Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Lehmann

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Cancer Research|March 26, 2014
Mislocalization of the cell polarity protein scribble promotes mammary tumorigenesis and is associated with basal breast cancerMichael E Feigin, S Dipikaa Akshinthala, Kiyomi Araki, et al.
Cancers|April 3, 2021
Annexin A1 Is Required for Efficient Tumor Initiation and Cancer Stem Cell Maintenance in a Model of Human Breast CancerCameron N Johnstone, Yan Tu, Shenna Langenbach, et al.
Nature Communications|September 1, 2021
Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypesLindsay N Redman-Rivera, Timothy M Shaver, Hailing Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancerKe-Da Yu, Rui Zhu, Ming Zhan, et al.
Plos One|April 17, 2020
Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsetsOlga Y Korolkova, Sarrah E Widatalla, Diva S Whalen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibitionKatherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
Advances in Enzyme Regulation|March 27, 2007
Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistanceJames A McCubrey, Linda S Steelman, Richard A Franklin, et al.
Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Oncotarget|May 15, 2015
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancerAndrew J Wilson, Oluwole Fadare, Alicia Beeghly-Fadiel, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Cancer Research|March 26, 2014
Mislocalization of the cell polarity protein scribble promotes mammary tumorigenesis and is associated with basal breast cancerMichael E Feigin, S Dipikaa Akshinthala, Kiyomi Araki, et al.
Cancers|April 3, 2021
Annexin A1 Is Required for Efficient Tumor Initiation and Cancer Stem Cell Maintenance in a Model of Human Breast CancerCameron N Johnstone, Yan Tu, Shenna Langenbach, et al.
Nature Communications|September 1, 2021
Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypesLindsay N Redman-Rivera, Timothy M Shaver, Hailing Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancerKe-Da Yu, Rui Zhu, Ming Zhan, et al.
Plos One|April 17, 2020
Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsetsOlga Y Korolkova, Sarrah E Widatalla, Diva S Whalen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibitionKatherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
Advances in Enzyme Regulation|March 27, 2007
Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistanceJames A McCubrey, Linda S Steelman, Richard A Franklin, et al.
Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Oncotarget|May 15, 2015
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancerAndrew J Wilson, Oluwole Fadare, Alicia Beeghly-Fadiel, et al.
Pageof 7